{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T20:11:00Z","timestamp":1777061460333,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503146"],"award-info":[{"award-number":["81503146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.bbrc.2018.09.183","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T22:37:02Z","timestamp":1538865422000},"page":"858-864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Antibiotic anisomycin selectively targets leukemia cell lines and patient samples through suppressing Wnt\/\u03b2-catenin signaling"],"prefix":"10.1016","volume":"505","author":[{"given":"Yong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongping","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.09.183_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.09.183_bib2","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2018.09.183_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/asheducation-2007.1.384","article-title":"The Biology of CML blast crisis","author":"Radich","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bbrc.2018.09.183_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","article-title":"How I treat CML blast crisis","volume":"120","author":"Hehlmann","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.09.183_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.09.183_bib6","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1016\/S0021-9258(18)95953-3","article-title":"Inhibitors of protein biosynthesis. II. Mode of action of anisomycin","volume":"242","author":"Grollman","year":"1967","journal-title":"J.\u00a0Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.bbrc.2018.09.183_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1469-7793.1997.517bd.x","article-title":"Evidence of two mechanisms for the activation of the glucose transporter GLUT1 by anisomycin: p38(MAP kinase) activation and protein synthesis inhibition in mammalian cells","volume":"504","author":"Barros","year":"1997","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.bbrc.2018.09.183_bib8","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3109\/10428194.2013.866664","article-title":"Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK\/JNK","volume":"55","author":"Liu","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbrc.2018.09.183_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/CAD.0000000000000450","article-title":"Enhancement of death receptor 4-mediated apoptosis and cytotoxicity in renal cell carcinoma cells by anisomycin","volume":"28","author":"Li","year":"2017","journal-title":"Anti Canccer Drugs"},{"key":"10.1016\/j.bbrc.2018.09.183_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bbrc.2016.05.139","article-title":"Anisomycin-induced GATA-6 degradation accompanying a decrease of proliferation of colorectal cancer cell","volume":"478","author":"Ushijima","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.09.183_bib11","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3892\/or.2016.4571","article-title":"Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion","volume":"35","author":"Chen","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2018.09.183_bib12","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1158\/1535-7163.MCT-07-0278","article-title":"Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim","volume":"6","author":"Abayasiriwardana","year":"2007","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2018.09.183_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10863-017-9734-8","article-title":"Antibiotic anisomycin induces cell cycle arrest and apoptosis through inhibiting mitochondrial biogenesis in osteosarcoma","volume":"49","author":"Cao","year":"2017","journal-title":"J.\u00a0Bioenerg. Biomembr."},{"key":"10.1016\/j.bbrc.2018.09.183_bib14","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.3892\/or.2013.2355","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of anisomycin against Ehrlich ascites carcinoma","volume":"29","author":"You","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2018.09.183_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biopha.2012.11.005","article-title":"Synergistic induction of TRAIL-mediated apoptosis by anisomycin in human hepatoma cells via the BH3-only protein Bid and c-Jun\/AP-1 signaling pathway","volume":"67","author":"Jin","year":"2013","journal-title":"Biomedicine & pharmacotherapy\u00a0= Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.bbrc.2018.09.183_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4149\/neo_2013_014","article-title":"Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK","volume":"60","author":"Liu","year":"2013","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbrc.2018.09.183_bib17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbrc.2016.08.047","article-title":"Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk\/Mnk1\/eIF4E pathway","volume":"478","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.09.183_bib18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0960-9822(03)00240-9","article-title":"Zebrafish prickle, a modulator of noncanonical Wnt\/Fz signaling, regulates gastrulation movements","volume":"13","author":"Veeman","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbrc.2018.09.183_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"el-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.09.183_bib20","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.M111023200","article-title":"Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter","volume":"277","author":"Korchynskyi","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.09.183_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2015.09.140","article-title":"Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt\/beta-catenin signaling","volume":"467","author":"Li","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.09.183_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5581\/1516-8484.20110124","article-title":"Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia","volume":"33","author":"Bitencourt","year":"2011","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"10.1016\/j.bbrc.2018.09.183_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.09.183_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"Li","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2018.09.183_bib25","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2013-05-501460","article-title":"Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression","volume":"122","author":"Laperrousaz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.09.183_bib26","doi-asserted-by":"crossref","first-page":"36420","DOI":"10.1074\/jbc.M110.137471","article-title":"The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2)","volume":"285","author":"Kim","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.09.183_bib27","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1600-0501.2012.02488.x","article-title":"GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces","volume":"24","author":"Galli","year":"2013","journal-title":"Clin. Oral Implants Res."},{"key":"10.1016\/j.bbrc.2018.09.183_bib28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2018.09.183_bib29","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2018.09.183_bib30","doi-asserted-by":"crossref","first-page":"E2298","DOI":"10.1073\/pnas.1301838110","article-title":"Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function","volume":"110","author":"Lim","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18321247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18321247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T14:18:10Z","timestamp":1662214690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18321247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0006291X18321247"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.183","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic anisomycin selectively targets leukemia cell lines and patient samples through suppressing Wnt\/\u03b2-catenin signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}